Published in Am J Kidney Dis on May 01, 1993
Kidney and recipient weight incompatibility reduces long-term graft survival. J Am Soc Nephrol (2010) 2.08
Kidneys at higher risk of discard: expanding the role of dual kidney transplantation. Am J Transplant (2014) 1.15
Effects of maternal vitamin A status on kidney development: a pilot study. Pediatr Nephrol (2006) 0.95
Nephron supply is a major determinant of long-term renal allograft outcome in rats. J Clin Invest (1994) 0.93
Donor-recipient gender and size mismatch affects graft success after kidney transplantation. J Am Coll Surg (2010) 0.90
HLA and cross-reactive antigen group matching for cadaver kidney allocation. Transplantation (1997) 0.89
Growth factor-dependent branching of the ureteric bud is modulated by selective 6-O sulfation of heparan sulfate. Dev Biol (2011) 0.88
Nephron number determines susceptibility to renal mass reduction-induced CKD in Lewis and Fisher 344 rats: implications for development of experimentally induced chronic allograft nephropathy. Nephrol Dial Transplant (2008) 0.86
Prematurity in mice leads to reduction in nephron number, hypertension, and proteinuria. Transl Res (2011) 0.86
Assessment and management of hypertension in transplant patients. J Am Soc Nephrol (2015) 0.81
Impact of donor-recipient gender on kidney graft and patient survival: short- and long-term outcomes. World J Urol (2013) 0.78
Donor-Recipient Weight and Sex Mismatch and the Risk of Graft Loss in Renal Transplantation. Clin J Am Soc Nephrol (2017) 0.78
Acoustic Radiation Force Impulse Measurement in Renal Transplantation: A Prospective, Longitudinal Study With Protocol Biopsies. Medicine (Baltimore) (2015) 0.77
Nephron-deficient Fvb mice develop rapidly progressive renal failure and heavy albuminuria involving excess glomerular GLUT1 and VEGF. Lab Invest (2009) 0.77
Donor and recipient size mismatch in adolescents undergoing living-donor renal transplantation affect long-term graft survival. Transplantation (2013) 0.77
Urinary transforming growth factor beta1 in children and adolescents with congenital solitary kidney. Pediatr Nephrol (2008) 0.76
Does graft mass impact on pediatric kidney transplant outcomes? Pediatr Nephrol (2014) 0.75
P-selectin expression in cold preserved kidneys in University of Wisconsin and histidine-tryptophan-ketoglutarate solutions. J Surg Res (2009) 0.75
Effect of earlier-proteinuria on graft functions after one-year living donor renal transplantation. Oncotarget (2017) 0.75
Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med (1999) 15.69
A compendium of gene expression in normal human tissues. Physiol Genomics (2001) 5.66
Transmission of hepatitis C virus by organ transplantation. N Engl J Med (1991) 5.17
T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature (1990) 4.40
Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs. N Engl J Med (1992) 2.78
Immunologic tolerance to renal allografts after bone marrow transplants from the same donors. Ann Intern Med (1991) 2.46
Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients. N Engl J Med (1987) 2.16
HLA gene and haplotype frequencies in the North American population: the National Marrow Donor Program Donor Registry. Transplantation (1997) 1.71
Type I diabetes mellitus in monozygotic twins: chronic progressive beta cell dysfunction. Ann Intern Med (1983) 1.68
Differences in access to cadaveric renal transplantation in the United States. Am J Kidney Dis (2000) 1.67
Avoidance of cyclosporine in renal transplantation: effects of daclizumab, mycophenolate mofetil, and steroids. J Am Soc Nephrol (2000) 1.45
A novel united network for organ sharing region kidney allocation plan improves transplant access for minority candidates. Transplantation (1999) 1.37
New recombinant HLA-B alleles in a tribe of South American Amerindians indicate rapid evolution of MHC class I loci. Nature (1992) 1.36
Two genes required for diabetes in BB rats. Evidence from cyclical intercrosses and backcrosses. J Exp Med (1984) 1.28
Early experience with dual kidney transplantation in adults using expanded donor criteria. Double Kidney Transplant Group (DKG). J Am Soc Nephrol (1999) 1.25
In renal transplantation, one size may not fit all. J Am Soc Nephrol (1992) 1.12
Prevention of acute allograft rejection by antibody targeting of TIRC7, a novel T cell membrane protein. Immunity (1998) 1.04
Probability of finding HLA-mismatched related or unrelated marrow or cord blood donors. Hum Immunol (2000) 1.04
Treatment of acute renal allograft rejection with monoclonal anti-T12 antibody. Transplantation (1983) 1.04
Early experience with anti-Tac in clinical renal transplantation. Transplant Proc (1989) 1.01
Antigen-independent determinants of cadaveric kidney transplant failure. JAMA (1996) 0.99
Colonic perforations after renal transplantation. J Am Coll Surg (1997) 0.96
The pathology of transfusion-related acute lung injury. Am J Clin Pathol (1999) 0.95
Evidence for functional heterogeneity of rat CD4+ T cells in vivo. Differential expression of IL-2 and IL-4 mRNA in recipients of cardiac allografts. J Immunol (1992) 0.95
Thy-1.1 in glomeruli of rat kidneys. Kidney Int (1984) 0.95
Molecular identification using flow cytometry histograms and information theory. Proc AMIA Symp (2001) 0.93
Accelerated rejection of renal allografts from brain-dead donors. Ann Surg (2000) 0.92
Prolongation of primate renal allograft survival by anti-Tac, an anti-human IL-2 receptor monoclonal antibody. Transplantation (1989) 0.92
Experience with cyclosporine and steroids in clinical renal transplantation. Ann Surg (1984) 0.92
Final analysis of primary cytomegalovirus disease prevention in renal transplant recipients with a cytomegalovirus-immune globulin: comparison of the randomized and open-label trials. Transplant Proc (1991) 0.92
Prevention of graft-versus-host disease following small bowel transplantation with polyclonal and monoclonal antilymphocyte serum. The effect of timing and route of administration. Transplantation (1991) 0.90
Monoclonal anti-IL-2 receptor antibody in primate renal transplantation. Transplant Proc (1987) 0.90
Soluble class I HLA antigens in patients with rheumatoid arthritis and their families. J Rheumatol (1995) 0.89
Long-term results of cyclosporine treatment in renal transplantation. Transplant Proc (1986) 0.89
A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantation. Transplantation (1991) 0.89
Computer program to predict likelihood of finding and HLA-matched donor: methodology, validation, and application. Biol Blood Marrow Transplant (1996) 0.87
Effects of BWH-4 anti-CD4 monoclonal antibody on rat vascularized cardiac allografts before and after engraftment. Transplantation (1991) 0.86
Non-immunologic predictors of chronic renal allograft failure: data from the United Network of Organ Sharing. Kidney Int Suppl (1995) 0.85
Multiparameter flow cytometric analysis of lymphocyte subpopulation activation in lectin-stimulated cultures. J Immunol (1982) 0.85
Organ transplantation--barriers, outcomes, and evolving policies. JAMA (1998) 0.85
Regulation of the immune response to alloantigens: suppressor and helper T cells generated in the primary MLR of the rat. J Immunol (1983) 0.84
Poorer graft survival in African-American transplant recipients cannot be explained by HLA mismatching. Adv Ren Replace Ther (1997) 0.84
In vivo activity of mixed lymphocyte response-generated suppressor cells and ability to prolong cardiac allograft survival in rats. Transplantation (1989) 0.84
Nocardial infection in a renal transplant recipient on tacrolimus and mycophenolate mofetil. Clin Nephrol (1999) 0.83
Evidence that therapeutic strategies targeted at CD4+ cells modulate accelerated rejection of cardiac allografts in sensitized rats by different mechanisms. Transplantation (1992) 0.83
Classifying antibodies using flow cytometry data: class prediction and class discovery. Biom J (2005) 0.82
Conversion from cyclosporine to azathioprine in renal allograft recipients. Transplantation (1984) 0.82
Function and migration of suppressor lymphocytes from cyclosporine-treated heart graft recipients. Transplantation (1983) 0.82
A further analysis of primary cytomegalovirus disease prevention in renal transplant recipients with a cytomegalovirus immune globulin: interim comparison of a randomized and an open-label trial. Transplant Proc (1988) 0.82
Requirements for the induction of allospecific CD8+ suppressor T cells in the rat primary mixed lymphocyte response. CD4+, CD45R+ T cells, or supernatant factor. Transplantation (1989) 0.81
Differential IL-2 receptor expression in renal allograft recipients treated with an anti-IL-2-receptor antibody. Transplantation (1989) 0.81
Histocompatibility antigens in primary biliary cirrhosis. Am J Gastroenterol (1987) 0.81
Blocking of mononuclear cell accumulation, cytokine production, and endothelial activation within rat cardiac allografts by CD4 monoclonal antibody therapy. Transplantation (1992) 0.81
Prolongation of primate renal allografts with anti-Tac monoclonal antibody. Curr Surg (1988) 0.79
Suppression of renal allograft rejection by low density thymocytes. Transplant Proc (1981) 0.79
Soluble HLA-II expression in African-Americans. Inflamm Res (2002) 0.79
Expression of RT1.A and RT1.B/D antigens on endothelium of rat kidneys. Transplantation (1982) 0.79
Mixed lymphocyte response-generated suppressor cell specificity in humans is major histocompatibility complex-restricted. Hum Immunol (1989) 0.78
Detecting antibodies with similar reactivity patterns in the HLDA8 blind panel of flow cytometry data. J Immunol Methods (2005) 0.78
Interleukin 2 receptor expression on peripheral blood lymphocytes in association with renal allograft rejection. Transplantation (1989) 0.78
Differential role of CD4+ cells in the sensitization and effector phases of accelerated graft rejection. Transplantation (1991) 0.78
Will transplant immunogenetics lead to better graft survival in blacks? Racial variability in the accuracy of tissue typing for organ donation: the fourth American workshop. Transplant Proc (1987) 0.77
Initial experience of dual maintenance immunosuppression with steroid withdrawal in vascular composite tissue allotransplantation. Am J Transplant (2015) 0.77
Low risk of liver disease after tissue transplantation from donors with HCV. Lancet (1993) 0.77
Modulation of acute and hyperacute rejection of xenografts in concordant hamster-to-rat combination. Transplant Proc (1993) 0.77
Donor pretreatment with monoclonal antibody for prevention of graft-versus-host disease following small bowel transplantation: effect of depletion of T-cell subsets. Transplant Proc (1991) 0.77
Evidence for a second class II (Ia) antigenic system in rats linked to RT1. Transplant Proc (1979) 0.77
Selective sparing of T suppressor cells by anti interleukin-2 receptor monoclonal antibodies (IL-2R mAbs) in vitro correlates with their therapeutic effects in vivo. Transplant Proc (1989) 0.77
Angiotensin gene polymorphism as a determinant of posttransplantation renal dysfunction and hypertension. Transplantation (2001) 0.77
MLR-reactive thymocytes in the rat: Ia-positive stimulator and Ia-negative responder cells. Transplant Proc (1979) 0.77
Presensitization and the renal allograft recipient. Transplantation (1989) 0.77
Selective sparing of suppressor cells generated in mixed lymphocyte response by an anti-interleukin-2 receptor antibody. Transplantation (1989) 0.76
Prophylactic use of monoclonal anti-IL-2 receptor antibody in cadaveric renal transplantation. Am J Kidney Dis (1989) 0.76
A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantation. Transplant Proc (1991) 0.76
Ten-year experience with cyclosporine as primary immunosuppression in recipients of renal allografts. Ann Surg (1991) 0.75
Liver disease and HCV infection after transplantation of organs from hepatitis C antibody positive donors. Transplant Proc (1993) 0.75
The effect of historical crossmatches and sensitization of renal allograft survival. Transplant Proc (1989) 0.75
Intragraft immune events causing vascularized organ graft rejection. Transplant Proc (1978) 0.75
A new allocation plan for renal transplantation. Transplantation (1999) 0.75
T cell activation in cardiac transplant recipients. Transplantation (1994) 0.75
HLA-B alleles of the Navajo: no evidence for rapid evolution in the Nadene. Tissue Antigens (1996) 0.75
Expression of alloantigens on the endothelium of ACI strain kidneys. Transplant Proc (1981) 0.75
HLA-B, DR matching and cadaver renal allograft survival in New England. New England Organ Bank. Transplant Proc (1989) 0.75
Clinical experience with cyclosporine and azathioprine at Brigham and Women's Hospital. Am J Kidney Dis (1985) 0.75
The role of a primate model of renal transplantation in the development of new monoclonal antibodies. Am J Kidney Dis (1989) 0.75
In vivo anti-interleukin-2 receptor (anti-Tac) therapy is immunosuppressive, but not tolerogenic. Trans Assoc Am Physicians (1989) 0.75
Monoclonal anti-T12 antibody as therapy for renal allograft rejection. Trans Assoc Am Physicians (1983) 0.75
CD4 MAb therapy diminishes sensitization to xenoantigen and abrogates hyperacute rejection of hamster cardiac grafts in rats. Transplant Proc (1992) 0.75
Antigen-independent determinants of graft survival in living-related kidney transplantation. Kidney Int Suppl (1997) 0.75
Anti-CD4 monoclonal antibody effects cellular hyporesponsiveness and prolongs renal allograft survival in the rat. Hum Immunol (1989) 0.75
The importance of targeting the CD4+ T cell subset at the time of antigenic challenge for induction of prolonged vascularized allograft survival. Transplantation (1992) 0.75
HLA class II-restricted binding of muramyl peptides to B lymphocytes of normal and narcoleptic subjects. Hum Immunol (1990) 0.75
Evidence that monoclonal antibodies against the 55kD subunit of the rat IL-2 receptor do not inhibit the development of suppressor cells generated in mixed lymphocyte culture. Transplantation (1990) 0.75
Decrease in phenotypically defined T helper inducer cells (T4+4B4+) and increase in T suppressor effector cells (T8+2H4+) in stable renal allograft recipients. Transplantation (1989) 0.75
The New England Organ Bank--lessons from running a regional organ bank. Clin Transpl (1993) 0.75
Expression of the Ag-F differentiation antigen on T-lymphocyte blasts and cytotoxic cells. Transplant Proc (1979) 0.75
Antigen specificity of mixed lymphocyte response-induced suppressor cells. Hum Immunol (1987) 0.75
Beneficial effects of monoclonal antibody targeting of CD4+ cells during the sensitisation but not effector phase of accelerated rejection of rat cardiac allografts. Transplant Proc (1990) 0.75
Therapeutic strategies targeted at CD4+ cells obviate accelerated rejection of cardiac allografts in sensitized rats. Transplant Proc (1991) 0.75